Literature DB >> 12787080

Post-transcriptional suppression of pathogenic prion protein expression in Drosophila neurons.

Nathan R Deleault1, Patrick J Dolph, Mel B Feany, Meghan E Cook, Koren Nishina, David A Harris, Surachai Supattapone.   

Abstract

A wealth of evidence supports the view that conformational change of the prion protein, PrPC, into a pathogenic isoform, PrPSc, is the hallmark of sporadic, infectious, and inherited forms of prion disease. Although the central role played by PrPSc in the pathogenesis of prion disease is appreciated, the cellular mechanisms that recognize PrPSc and modulate its production, clearance, and neural toxicity have not been elucidated. To address these questions, we used a tissue-specific expression system to express wild-type and disease-associated PrP molecules heterologously in Drosophila melanogaster. Our results indicate that Drosophila brain possesses a specific and saturable mechanism that suppresses the accumulation of PG14, a disease-associated insertional PrP mutant. We also found that wild-type PrP molecules are maintained in a detergent-soluble conformation throughout life in Drosophila brain neurons, whereas they become detergent-insoluble in retinal cells as flies age. PG14 protein expression in Drosophila eye did not cause retinal pathology. Our work reveals the presence of mechanisms in neurons that specifically counterbalance the production of misfolded PrP conformations, and provides an opportunity to study these processes in a model organism amenable to genetic analysis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787080     DOI: 10.1046/j.1471-4159.2003.01819.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

Review 1.  Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.

Authors:  Pedro Fernandez-Funez; Jonatan Sanchez-Garcia; Diego E Rincon-Limas
Journal:  Curr Opin Genet Dev       Date:  2017-04-14       Impact factor: 5.578

Review 2.  Prion disease modelled in Drosophila.

Authors:  Raymond Bujdoso; Andrew Smith; Oliver Fleck; John Spiropoulos; Olivier Andréoletti; Alana M Thackray
Journal:  Cell Tissue Res       Date:  2022-01-29       Impact factor: 5.249

3.  Exploring prion protein biology in flies: genetics and beyond.

Authors:  Diego E Rincon-Limas; Sergio Casas-Tinto; Pedro Fernandez-Funez
Journal:  Prion       Date:  2010-01-30       Impact factor: 3.931

Review 4.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

5.  In vivo generation of neurotoxic prion protein: role for hsp70 in accumulation of misfolded isoforms.

Authors:  Pedro Fernandez-Funez; Sergio Casas-Tinto; Yan Zhang; Melisa Gómez-Velazquez; Marco A Morales-Garza; Ana C Cepeda-Nieto; Joaquín Castilla; Claudio Soto; Diego E Rincon-Limas
Journal:  PLoS Genet       Date:  2009-06-05       Impact factor: 5.917

6.  Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine.

Authors:  Genny Orso; Andrea Martinuzzi; Maria Giovanna Rossetto; Elena Sartori; Mel Feany; Andrea Daga
Journal:  J Clin Invest       Date:  2005-11       Impact factor: 14.808

7.  In vivo expression of peptidylarginine deiminase in Drosophila melanogaster.

Authors:  Olena Mahneva; Monica G Risley; Ciny John; Sarah L Milton; Ken Dawson-Scully; William W Ja
Journal:  PLoS One       Date:  2020-01-15       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.